research Androgenetic Alopecia in COVID-19: Comparison to Age-Matched Epidemiologic Studies and Hospital Outcomes With or Without the Gabrin Sign
AGA linked to worse COVID-19 outcomes in men.
Search
for
Sort by
Research
180-210 / 1000+ results 
research Impact of Androgen Deprivation Therapy on Mortality of Prostate Cancer Patients with COVID-19: A Propensity Score-Based Analysis
Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.
research Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 Participants
COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.
research Impact of Anti-Androgen Therapies on COVID-19 Susceptibility: A Case-Control Study in Male Population from Two COVID-19 Regional Centers of Lombardy, Italy
Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.
research Skin Tissue: A Place for SARS-CoV-2 to Multiply and Transmit?
SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.
research Evaluating the Role of Thyroid Stimulating Hormone and Ferritin Levels with Hair Loss Among Patients with COVID-19: Case-Control Study
Thyroid function may influence hair loss after COVID-19.
research Telogen Effluvium After COVID-19 Infection: A Narrative Review of the Physiological Mechanism
COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.
research The Role of Androgens in Androgenetic Alopecia Associated with the Severity of COVID-19
Androgens play a key role in causing alopecia by changing the hair growth cycle.
research The Association Between Hair Loss and COVID-19: Impact on Quality of Life in Saudi Arabia
Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.
research Selected Psychological Stress and Cognitive Function Parameters in Patients Suffering from COVID-19 Induced Telogen Effluvium
COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.
research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation
COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.
research Androgenetic Alopecia as a Complication of SARS-CoV-2 Infection
People with androgenetic alopecia may have a higher risk of severe COVID-19.
research Reporting Cases of Telogen Effluvium as a Sequelae of COVID-19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research Alopecia and Severity of COVID-19: A Cross-Sectional Study in Peru
Men with hair loss are more likely to experience moderate to severe COVID-19 symptoms.
research Telogen Effluvium, Beau's Lines, and Acral Peeling Associated with COVID-19 Infection
A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.
research Is COVID-19 a Risk Factor for Progression of Benign Prostatic Hyperplasia and Exacerbation of Its Related Symptoms?: A Systematic Review
COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.
research Reply to Letter to the Editor: A Response to 'Male Balding Is a Major Risk Factor for Severe COVID-19'
Balding might help identify men at higher risk for severe COVID-19, but more research is needed.
research Male Balding Is a Major Risk Factor for Severe COVID-19
Men with severe balding have a higher risk of getting very sick from COVID-19.
research 067 BELCOMID: Belgian Cohort Study of COVID-19 in Immune Mediated Inflammatory Diseases
COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.
research Gestational Diabetes Mellitus and COVID-19: Clinical Characteristics and Literature Review
Pregnant women with COVID-19 and gestational diabetes may face severe complications, and more research is needed on their outcomes.
research The Double-Edged Sword of Testosterone’s Role in the COVID-19 Pandemic
Testosterone may influence COVID-19 severity and outcomes.
research Are the Cutaneous Manifestations During or Due to SARS-CoV-2 Infection/COVID-19 Frequent or Not? Revision of Possible Pathophysiologic Mechanisms
Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.
research Teledermatology in the COVID-19 Pandemic: A Systematic Review
Teledermatology became a valuable and convenient tool for skin care during the COVID-19 pandemic.
research Severe COVID-19 Infection Predisposes Patients to Greater Burden of Hair Loss
People who had severe COVID-19 are more likely to experience hair loss.
research Psychological Stress and Cognitive Function in COVID-19 Induced Telogen Effluvium Patients
COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.
research A Cross-Sectional Study on Post-Coronavirus Disease Hair Loss at a Tertiary Care Hospital
Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.
research Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review
COVID-19 may trigger or worsen rapid hair loss in alopecia areata.
research Defining the Short-Term and Long-Term Skin Manifestations of COVID-19: Insights After More Than Three Years of the Pandemic
COVID-19 can cause various skin issues, but long-term skin problems are rare.
research Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review
COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.
research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.